Home
   
The Company
The History of SocraTec R&D
Our Goals and Visions
Our Services
Quality Management System
Cooperation Partners
Contact / Location
Clinical Investigations
Clinical Pharmacology Unit
Phase-I Studies
Phase-II/III Studies
Absorption-Site Studies
Proof-of-Concept Studies
Special Populations
Oncology
Magnetic Marker Monitoring
Procedure, Basic Principle
Testing Unit
Study Experience
Applications
Biopharmaceutics
Drug Substance
Dosage Form
BSC Classification
Product Improvement
Brain Trust, Expertise
Consulting Service
Expert Reports
Network of Experts
Development Concepts
Infocentre
Lectures/Presentations
Publications/Review Articles
Seminars/Conferences
Links
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Pharmaceutical form - converting ingredients into medicines

Is it preferable to make a medicine that is absorbed quickly or retarded? Can patient compliance be significantly improved by the treatment with dosage forms for once-daily administration? And finally, which route of application allows optimum achievement of the therapeutic effects?

All these aspects are highly relevant for successful pharmaco-therapy and thus must be considered systematically in order to evaluate a consistent clinical development rationale. In this context the special needs of the patients should not be disregarded. Consequently, a successful development of therapeutically optimized dosage forms requires purposeful inter-disciplinary collaboration. In this context

concrete clinical goals have to be defined - at best supported by a scientific rationale based on underlying molecular-biological mechanisms,

the physiologic conditions for optimum absorption of the active drug ingredients have to be investigated,

a biopharmaceutical rationale for the pharmaceutical formulation has to be developed and

the needs and expectations of the patient population have to be defined.


We look forward to supporting your development activities with our expertise. Whereby you can benefit from our wide experience in designing and conducting absorption-site studies, in visualizing the gastro-intestinal transit of solid oral dosage forms by means of imaging techniques and the biopharmaceutical optimization of medicinal products. Furthermore we provide support in the clinical characterization of development products for registration purposes.

 
 
  © 2003-2013 SocraTec R&D GmbH deutsche Version Imprint